Period Ending | Dec 28, 2012 | Sep 28, 2012 | Jun 29, 2012 | Mar 30, 2012 |
---|
Total Revenue
|
13,477,000
|
13,457,000
|
13,501,000
|
12,906,000
| Cost of Revenue | 5,660,000 | 4,942,000 | 4,947,000 | 4,641,000 | |
Gross Profit
|
7,817,000
|
8,515,000
|
8,554,000
|
8,265,000
| |
|
Operating Expenses |
|
Research Development | 2,629,000 | 2,605,000 | 2,513,000 | 2,401,000 |
|
Selling General and Administrative | 1,958,000 | 1,995,000 | 2,131,000 | 1,973,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 75,000 | 74,000 | 78,000 | 81,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
3,155,000
|
3,841,000
|
3,832,000
|
3,810,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 3,204,000 | 3,921,000 | 3,934,000 | 3,814,000 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 3,204,000 | 3,921,000 | 3,934,000 | 3,814,000 |
|
Income Tax Expense | 736,000 | 949,000 | 1,107,000 | 1,076,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 2,528,000 | 3,025,000 | 2,874,000 | 2,719,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
2,468,000
|
2,972,000
|
2,827,000
|
2,738,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
2,468,000
|
2,972,000
|
2,827,000
|
2,738,000
|
|